AI pathology firm Proscia nets $37M investment

By Author Proscia | June 14, 2022

Founded in 2014, the data-driven software developer uses digital images rather than microscopes to advance precision medicine and pathology in the oncology field. The company said the funding will help scale its commercial operations, grow its distribution partnerships and expand its sales, marketing and support teams.

Our website uses cookies. By using this site, you agree to its use of cookies.